Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
MediWound Ltd. (MDWD)
Price$13.29Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0M | $20.2M | $18.7M | $26.5M | $23.8M | $21.8M | $31.8M | $3.4M | $2.5M | $1.6M | $601,000 |
| Gross profit | $3.3M | $2.6M | $3.6M | $13.2M | $8.8M | $7.5M | $19.9M | $1.3M | $918,000 | −$600,000 | −$1.9M |
| Gross margin | 19.19% | 13.03% | 19.15% | 49.69% | 36.91% | 34.67% | 62.73% | 38.61% | 36.78% | −38.51% | −319.13% |
| Research & development | $14.3M | $8.9M | $7.5M | $10.2M | $10.3M | $7.7M | $5.0M | $4.1M | $5.5M | $7.1M | $6.0M |
| Operating expenses | $28.5M | $22.0M | $18.9M | $21.5M | $20.0M | $16.4M | $15.4M | $5.3M | $14.6M | $19.6M | $19.3M |
| Operating income | −$25.3M | −$19.4M | −$15.3M | −$8.3M | −$11.2M | −$8.8M | $4.5M | −$4.0M | −$13.7M | −$20.2M | −$21.2M |
| Operating margin | −148.98% | −95.94% | −81.83% | −31.50% | −47.22% | −40.62% | 14.13% | −116.44% | −548.36% | −1,293.65% | −3,531.95% |
| EBITDA | −$24.7M | −$18.8M | −$14.6M | −$7.9M | −$10.7M | −$8.5M | $5.0M | −$3.5M | −$13.2M | −$19.7M | −$20.8M |
| EBITDA margin | −145.50% | −92.82% | −78.23% | −29.89% | −44.87% | −38.84% | 15.74% | −102.50% | −530.05% | −1,263.16% | −3,462.56% |
| Net income | −$23.9M | −$30.2M | −$6.7M | −$19.6M | −$13.6M | −$9.2M | $5.0M | −$1.1M | −$22.1M | −$18.9M | −$22.1M |
| Net profit margin | −140.80% | −149.46% | −35.94% | −73.97% | −57.03% | −42.26% | 15.59% | −31.08% | −887.38% | −1,212.13% | −3,675.21% |
| Basic EPSper basic share | -$2.10 | -$3.03 | -$0.75 | -$3.93 | -$3.48 | -$2.38 | $1.26 | -$0.28 | -$6.65 | -$6.02 | -$7.14 |
| Diluted EPSper diluted share | -$2.10 | -$3.03 | -$0.75 | -$3.93 | -$3.48 | -$2.38 | $1.26 | -$0.28 | -$6.65 | -$6.02 | -$7.14 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
INVESTOR AB | 872.09K |
Yelin Lapidot Holdings Management Ltd. | 758.17K |
Rosalind Advisors, Inc. | 749.05K |
PRICE T ROWE ASSOCIATES INC /MD/ | 641.08K |
BlackRock, Inc. | 525.93K |
SPHERA FUNDS MANAGEMENT LTD. | 273.19K |
Silverberg Bernstein Capital Management LLC | 228.14K |
STATE STREET CORP | 168.67K |
UBS Group AG | 155.92K |
GEODE CAPITAL MANAGEMENT, LLC | 141.04K |
Point72 Asset Management, L.P. | 129.25K |
ARK Investment Management LLC | 126.58K |
NORTHERN TRUST CORP | 112.19K |
DAFNA Capital Management LLC | 94.41K |
MORGAN STANLEY | 88.66K |
Clal Insurance Enterprises Holdings Ltd | 71K |
VANGUARD PORTFOLIO MANAGEMENT LLC | 70.14K |
Sargent Investment Group, LLC | 62.48K |
CITADEL ADVISORS LLC | 58.5K |
AQR CAPITAL MANAGEMENT LLC | 50.36K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026Form 4 | SHAMIR NACHUMDirector | BuyOrdinary Shares | 5.8K | $14.00 | $81.5K | 55.8K |
| Jun 3, 2026Form 4 | SHAMIR NACHUMDirector | BuyOrdinary Shares | 175 | $13.98 | $2.4K | 50.0K |
| Jun 1, 2026Form 4 | Fox David MortonDirector | BuyOrdinary Shares | 1.8K | $14.00 | $25.2K | 22.3K |
| Jun 1, 2026Form 4 | Fox David MortonDirector | BuyOrdinary Shares | 10 | $14.23 | $142.30 | 20.5K |
| Jun 1, 2026Form 4 | Fox David MortonDirector | BuyOrdinary Shares | 1.7K | $14.23 | $24.6K | 20.5K |